Collecting different types of data and expanding the pool of participants should be priorities for migraine clinical trials, according to speakers for the webinar, “The Value of Evidence-Based Treatments for Migraine Sufferers” hosted by Research!America on June 12. The webinar explored advances in migraine research to address gaps in prevention and treatment, development of new therapies, and methods for improving access to care.
One long-neglected area of research has been pediatric migraine. “Ten percent of all kids get migraines,” said Dr. Peter McAllister, medical director, New England Institute for Neurology and Headache, chief medical officer, New England Institute for Clinical Research and Ki Clinical Research. “Up until recently we conducted studies on adults and figured they may work in kids. But that’s changed, fortunately. We have several migraine studies now involving children 6 to 11-years-old.”
In addition, most clinical trials exclude women and men with comorbid conditions, such as migraine sufferers with fibromyalgia or painful disorders, said Dr. Jan Lewis Brandes, founder, Nashville Neuroscience Group and assistant clinical professor, Department of Neurology, Vanderbilt University School of Medicine. “We need to see how patients with more than one disorder really respond to the medication.”
Researchers should seek information from migraine patients regarding day-to-day tasks, said Dr. Lisa DeLeonardo, licensed psychologist and migraine patient. “I hope there’s a better way to capture more nuanced quality of life data because it’s much more meaningful to patients and to their treating physicians.”
Click here to view a recording of the webinar.